protocolSection identificationModule nctId: NCT06373692, orgStudyIdInfo id: TCM for Asthma Cohort, briefTitle: REspiratory diSEAse cohoRt Studies of CHinese Medicine for Asthma (RESEARCH- Asthma), statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-05-01, primaryCompletionDateStruct date: 2025-12-30, completionDateStruct date: 2026-12-30, studyFirstPostDateStruct date: 2024-04-18, lastUpdatePostDateStruct date: 2024-04-18, sponsorCollaboratorsModule leadSponsor name: Henan University of Traditional Chinese Medicine, class: OTHER, collaborators name: The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, collaborators name: Tianjin University of Traditional Chinese Medicine, collaborators name: The Third Affiliated Hospital of Henan University of Traditional Chinese Medicine, collaborators name: Hebei Provincial Hospital of Traditional Chinese Medicine, collaborators name: Peking University People's Hospital, collaborators name: The Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, collaborators name: The First Affiliated Hospital of Zhengzhou University, collaborators name: First Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, collaborators name: The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, descriptionModule briefSummary: The purpose of this study is to define the standard use of TCM treatment regimen as the TCM cohort group and the non-TCM cohort group of those who use conventional Western medicine treatment without the standard TCM treatment regimen through a multi-center, large-sample prospective cohort study design. To evaluate the clinical efficacy and safety of TCM treatment regimens in the treatment of bronchial asthma, and to provide high-quality evidence for the promotion and application of TCM syndrome differentiation treatment in bronchial asthma., conditionsModule conditions: Bronchial Asthma, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 1508, type: ESTIMATED, armsInterventionsModule, outcomesModule primaryOutcomes measure: Asthma control rate, secondaryOutcomes measure: Number of exacerbations, secondaryOutcomes measure: Asthma exacerbation severity, secondaryOutcomes measure: Change in severity of chronic persistent disease, secondaryOutcomes measure: The dose used by glucocorticoids, secondaryOutcomes measure: Rapid-acting beta2 agonists use drugs and doses, secondaryOutcomes measure: Asthma Control Test (ACT) score, secondaryOutcomes measure: Asthma Control Questionnaire (ACQ), secondaryOutcomes measure: Asthma Quality of Life Score (AQLQ), secondaryOutcomes measure: Anxiety Self-Assessment Form (SAS), secondaryOutcomes measure: Depression Self-Rating Scale (SDS), secondaryOutcomes measure: Pulmonary function, secondaryOutcomes measure: Exhaled nitric oxide (FeNO), eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 80 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, city: Zhengzhou, state: Henan, country: China, contacts name: Hai-bin Yu, Ph.D, role: CONTACT, phone: +86 13526671773, email: wwz1231125@163.com, geoPoint lat: 34.75778, lon: 113.64861, hasResults: False